Johnson & Johnson (JNJ)

Johnson & Johnson Stock Analysis & Ratings



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Johnson & Johnson’s price range in the past 12 months?
Johnson & Johnson lowest stock price was $153.87 and its highest was $185.50 in the past 12 months.
    What is Johnson & Johnson’s market cap?
    Currently, no data Available
    What is Johnson & Johnson’s price target?
    The average price target for Johnson & Johnson is $188.73. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
    The highest analyst price target is $215.00 ,the lowest forecast is $165.00. The average price target represents 10.58% Increase from the current price of $170.67.
      What do analysts say about Johnson & Johnson?
      Johnson & Johnson’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.
        When is Johnson & Johnson’s upcoming earnings report date?
        Johnson & Johnson’s upcoming earnings report date is Oct 18, 2022 which is in 68 days.
          How were Johnson & Johnson’s earnings last quarter?
          Johnson & Johnson released its earnings results on Jul 19, 2022. The company reported $2.59 earnings per share for the quarter, beating the consensus estimate of $2.537 by $0.053.
            Is Johnson & Johnson overvalued?
            According to Wall Street analysts Johnson & Johnson’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
              Does Johnson & Johnson pay dividends?
              Johnson & Johnson pays a Quarterly dividend of $1.13 which represents an annual dividend yield of 2.53%. Johnson & Johnson’s last Quarterly dividend payment was on Sep 06, 2022. Johnson & Johnson’s upcoming ex-dividend date is Aug 22, 2022
                What is Johnson & Johnson’s EPS estimate?
                Johnson & Johnson’s EPS estimate is $2.53.
                  How many shares outstanding does Johnson & Johnson have?
                  Johnson & Johnson has 2,629,180,000 shares outstanding.
                    What happened to Johnson & Johnson’s price movement after its last earnings report?
                    Johnson & Johnson reported an EPS of $2.59 in its last earnings report, beating expectations of $2.537. Following the earnings report the stock price went down -1.458%.
                      Which hedge fund is a major shareholder of Johnson & Johnson?
                      Among the largest hedge funds holding Johnson & Johnson’s share is Bridgewater Associates, LP. It holds Johnson & Johnson’s shares valued at 770M.


                        Johnson & Johnson Stock Analysis

                        Smart Score
                        Price Target
                        ▲(10.58% Upside)
                        Moderate Buy
                        The Johnson & Johnson stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                        Learn more about TipRanks Smart Score

                        Company Description

                        Johnson & Johnson

                        Johnson & Johnson provides healthcare products across three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

                        Similar Stocks
                        Price & Change
                        Eli Lilly & Co
                        Merck & Company
                        Bristol Myers

                        Popular Stocks

                        What's Included in PREMIUM?
                        Make informed decisions based on Top Analysts' activity
                        Know what industry insiders are buying
                        Get actionable alerts from top Wall Street Analysts
                        Find out before anyone else which stock is going to shoot up
                        Get powerful stock screeners & detailed portfolio analysis